Canine cancer study reveals alarming hemangiosarcoma prevalenceAugust 1, 2023Morris Animal Foundation’s Golden Retriever Lifetime Study has now reached a milestone with the accrual of 500 cumulative diagnoses of four major cancers in dogs: hemangiosarcoma, lymphoma, high-grade mast cell tumor, and osteosarcoma.
SPONSORED CONTENTOne dose protects for 12 months.One ProHeart® 12 (moxidectin) injection puts compliance in your control. + Get started
Canine cancer biomarkers to be exploredJune 23, 2021Determining early indicators of disease and helping dogs lead the longest, healthiest lives possible is the driving force behind Morris Animal Foundation’s latest partnership.
VPN Plus+ ExclusiveCurrent lifespan patterns in dogsJune 3, 2021By Brennen McKenzie, MA, MSc, VMD, cVMAResearch efforts are ongoing, and rapidly expanding, to aid our understanding of how aging happens to develop preventative and therapeutic interventions to delay age-associated disease, disability, and death.
National dog study to explore CDSApril 12, 2021Gaining insight into the incidence, prevalence, and varieties of a behavioral disorder impacting adult dogs is the driving force behind a newly announced partnership.
National study to shed light on canine OAMarch 22, 2021Gaining insight into the incidence and prevalence of canine osteoarthritis (OA) is the driving force behind a newly announced partnership.
Spaying and neutering large-breed dogs might increase risk of obesityJuly 23, 2019The advantages of the long-supported practice of spaying or neutering dogs are being questioned, thanks to new research based on data analyzed from the Morris Animal Foundation’s Golden Retriever Lifetime Study.
Morris Animal Foundation names new president and CEOSeptember 25, 2018Morris Animal Foundation announced that Tiffany Grunert is the organization's new president and CEO. Grunert, who joined the foundation in 2017 as vice president of marketing and brand strategy, has been serving as acting president and CEO since February 2018. Grunert takes charge of a $15 million annual budget, an $80 million endowment, and 40 employees. Morris Animal Foundation funds more than 200 scientific studies annually and has contributed more than $118 million over 70 years to advance the health and well-being of animals around the world. Established in 1948, it acts to advance veterinary medicine, protect endangered species, and train new scientists. "With Morris Animal Foundation's rich and beautiful history, and our bright future to continue to advance animal health, I am honored to serve as the next president and CEO," Grunert said. "The foundation's board of trustees has entrusted me with an organization of enormous importance and deep value. I recognize the magnitude of our current efforts and the need to advance our strategic initiatives to grow our impact. We must ensure that there is always a robust resource to improve animal health." As acting president and CEO, Grunert advanced the Golden Retriever Lifetime …
Morris Animal Foundation announces second National Dog Day campaignAugust 3, 2018Since 2004, National Dog Day has been observed on Aug. 26 to encourage dog ownership of mixed-breed and purebred dogs, and to remind us all that canine companions deserve to live long, healthy lives. That's why for the second year in a row, Morris Animal Foundation (MAF) is running a campaign this month through Aug. 26, in which an anonymous donor will match all gifts made to the Golden Retriever Lifetime Study, dollar for dollar, up to $50,000. The $32 million study gathers information on more than 3,000 golden retrievers throughout their lives to identify the nutritional, environmental, lifestyle, and genetic risk factors for cancer and other canine diseases. Its primary goal is to reveal potential risk factors that may lead to the development of four types of cancers common in golden retrievers: hemangiosarcoma, mast cell tumors, lymphoma, and osteosarcoma. Donations can be made to the Golden Retriever Lifetime Study at MAF's website here.
MAF explores study diversity, applications to animal healthSeptember 18, 2017According to a new research paper from the Morris Animal Foundation (MAF), determining what type of research study to do, and when, are key decisions scientists must make when embarking on a new project. In an editorial published Sept. 11, 2017, in the International Animal Health Journal, "Epidemiology and its Application to Animal Health," Missy Simpson, DVM, intramural research scientist and epidemiologist with MAF, provides guidance on study types for veterinary researchers and animal health scientists. The editorial is an overview of study types, and highlights MAF's Golden Retriever Lifetime Study as an example of a cohort study, and also discusses advances in store for observational studies. "Health research is diverse and varied and covers a spectrum from basic research—which describes the early discovery and development phase—to applied research," said Dr. Simpson. "Each phase of research is essential to move scientific discovery forward and advance health." In the paper, Simpson discusses interventional research consisting of clinical trials, and observational research, including descriptive studies, case-series studies, case-control studies, and ecologic, retrospective, and longitudinal studies. "An advantage of performing clinical trials in animals is that health outcomes tend to be achieved on …
